{"id":"https://openalex.org/W1997234050","doi":"https://doi.org/10.1159/000111092","title":"Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia","display_name":"Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W1997234050","doi":"https://doi.org/10.1159/000111092","mag":"1997234050","pmid":"https://pubmed.ncbi.nlm.nih.gov/18030002"},"language":"en","primary_location":{"id":"doi:10.1159/000111092","doi":"https://doi.org/10.1159/000111092","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000111092","pdf_url":null,"source":{"id":"https://openalex.org/S182948766","display_name":"Acta Haematologica","issn_l":"0001-5792","issn":["0001-5792","1421-9662"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Haematologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020404601","display_name":"Jee Hyun Kong","orcid":"https://orcid.org/0000-0001-7833-8480","observed_orcids":["https://orcid.org/0000-0001-7833-8480"]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jee Hyun Kong","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Seung-Hyun Yoo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seung-Hyun Yoo","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101534267","display_name":"Kyoung Eun Lee","orcid":"https://orcid.org/0000-0003-1596-8666","observed_orcids":["https://orcid.org/0000-0003-1596-8666","https://orcid.org/0000-0002-3955-7389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyoung Eun Lee","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Department of Internal Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112023624","display_name":"Seung Hyun Nam","orcid":"https://orcid.org/0009-0006-5761-0098","observed_orcids":["https://orcid.org/0009-0006-5761-0098"]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seung Hyun Nam","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jung Mi Kwon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jung Mi Kwon","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100342115","display_name":"Sang Min Lee","orcid":"https://orcid.org/0000-0002-7834-8272","observed_orcids":["https://orcid.org/0000-0002-7834-8272"]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sang Min Lee","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101715786","display_name":"Hye Jung Chang","orcid":"https://orcid.org/0000-0003-1341-8601","observed_orcids":["https://orcid.org/0000-0003-1341-8601"]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hye Jung Chang","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088383868","display_name":"Moon Young Choi","orcid":"https://orcid.org/0000-0002-6905-3114","observed_orcids":["https://orcid.org/0000-0002-6905-3114"]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Moon Young Choi","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113989159","display_name":"Min Sun Cho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Min Sun Cho","raw_affiliation_strings":["Pathology, School of Medicine, Ewha Womans University, Seoul, Korea","Department of Pathology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, School of Medicine, Ewha Womans University, Seoul, Korea","institution_ids":["https://openalex.org/I138925566"]},{"raw_affiliation_string":"Department of Pathology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054573839","display_name":"Yeung\u2010Chul Mun","orcid":"https://orcid.org/0000-0002-1882-3983","observed_orcids":["https://orcid.org/0000-0002-1882-3983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yeung-Chul Mun","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Department of Internal Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036775045","display_name":"Eunmi Nam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eunmi Nam","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Department of Internal Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030897866","display_name":"Soon Nam Lee","orcid":"https://orcid.org/0000-0003-3134-5100","observed_orcids":["https://orcid.org/0000-0003-3134-5100"]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Soon Nam Lee","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University","institution_ids":["https://openalex.org/I138925566"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103732499","display_name":"Chu\u2010Myong Seong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138925566","display_name":"Ewha Womans University","ror":"https://ror.org/053fp5c05","country_code":"KR","type":"education","lineage":["https://openalex.org/I138925566"]},{"id":"https://openalex.org/I4210132203","display_name":"Ewha Womans University Medical Center","ror":"https://ror.org/03exgrk66","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I138925566","https://openalex.org/I4210132203"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Chu-Myong Seong","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Internal Medicine, and","Ewha Womans University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Internal Medicine, and","institution_ids":[]},{"raw_affiliation_string":"Ewha Womans University Hospital","institution_ids":["https://openalex.org/I138925566","https://openalex.org/I4210132203"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.8323,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.892926,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"118","issue":"4","first_page":"205","last_page":"208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.3244999945163727,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"imatinib mesylate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.972000002861023},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cholestatic-liver-injury","display_name":"cholestatic liver injury","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hepatocyte-injury","display_name":"hepatocyte injury","score":0.7020000219345093},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.9620156288146973},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6798158884048462},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.6683365702629089},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6562154293060303},{"id":"https://openalex.org/C2780194963","wikidata":"https://www.wikidata.org/wiki/Q903441","display_name":"Mesylate","level":2,"score":0.5255569219589233},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5112247467041016},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.365797758102417},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.29785478115081787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25066569447517395},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1303599774837494},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.08248040080070496},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001652","descriptor_name":"Bile Ducts","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001752","descriptor_name":"Blast Crisis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002780","descriptor_name":"Cholestasis, Intrahepatic","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008111","descriptor_name":"Liver Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015255","descriptor_name":"Idarubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000111092","doi":"https://doi.org/10.1159/000111092","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000111092","pdf_url":null,"source":{"id":"https://openalex.org/S182948766","display_name":"Acta Haematologica","issn_l":"0001-5792","issn":["0001-5792","1421-9662"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Haematologica","raw_type":"journal-article"},{"id":"pmid:18030002","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18030002","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta haematologica","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W5199437","https://openalex.org/W1927701703","https://openalex.org/W1965295262","https://openalex.org/W2000629172","https://openalex.org/W2004577371","https://openalex.org/W2011474502","https://openalex.org/W2015015957","https://openalex.org/W2028959752","https://openalex.org/W2035160863","https://openalex.org/W2068639674","https://openalex.org/W2080334303","https://openalex.org/W2107907603","https://openalex.org/W2142969636","https://openalex.org/W2171722798","https://openalex.org/W2329648702","https://openalex.org/W2992837203","https://openalex.org/W4230152513"],"related_works":["https://openalex.org/W2337126246","https://openalex.org/W168259222","https://openalex.org/W2000629172","https://openalex.org/W3116441850","https://openalex.org/W1976529615","https://openalex.org/W2325511773","https://openalex.org/W2035160863","https://openalex.org/W1592992878","https://openalex.org/W4384662945","https://openalex.org/W2075852861"],"abstract_inverted_index":{"Imatinib":[0],"mesylate":[1,37,80],"is":[2],"the":[3,30,33,53,72,95],"first":[4],"molecule":[5],"of":[6,24,32,35,43,56,71,97],"targeted":[7],"therapy":[8],"in":[9],"chronic":[10],"myelogenous":[11],"leukaemia":[12],"inhibiting":[13],"constitutively":[14],"activated":[15],"BCR-ABL":[16],"kinase.":[17],"There":[18],"are":[19],"no":[20],"long-term":[21,54],"follow-up":[22],"studies":[23],"large":[25],"sample":[26],"sizes":[27],"to":[28],"assess":[29],"toxicity":[31],"use":[34,55,96],"imatinib":[36,57,79,98],"over":[38],"10":[39],"years.":[40],"Several":[41],"cases":[42],"hepatotoxicity,":[44],"including":[45],"fatal":[46],"liver":[47,73],"failure,":[48],"have":[49],"been":[50],"associated":[51,93],"with":[52,91,94],"mesylate.":[58,99],"We":[59],"report":[60],"here":[61],"on":[62],"a":[63],"patient":[64],"who":[65],"experienced":[66],"immediate":[67],"dominant":[68],"cholestatic":[69],"damage":[70,77],"and":[74],"mild":[75],"hepatocyte":[76],"during":[78],"therapy.":[81],"This":[82],"differs":[83],"from":[84],"most":[85],"reports":[86],"showing":[87],"dominantly":[88],"acute":[89],"hepatitis":[90],"necrosis":[92]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}